Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With... This study uses data from the Alberta Kidney Disease Network population database to evaluate the association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with posthospitalization outcomes in patients with acute kidney injury. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury

Loading next page...
 
/lp/american-medical-association/association-of-angiotensin-converting-enzyme-inhibitor-or-angiotensin-NxfK6m6WuF

References (54)

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2018.4749
Publisher site
See Article on Publisher Site

Abstract

This study uses data from the Alberta Kidney Disease Network population database to evaluate the association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with posthospitalization outcomes in patients with acute kidney injury.

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Dec 27, 2018

There are no references for this article.